MedTrace Logo

Arrival Time Implementation

NCT07314697 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300000

Last updated 2026-02-10

No results posted yet for this study

Summary

This is a prospective clinical trial evaluating how behaviorally informed message framing can improve patient on-time arrival for outpatient visits. This trial is being implemented in conjunction with UCLA Health's broader operational quality improvement (QI) efforts to enhance clinic flow and patient experience.

The main question it aims to answer is how displaying an explicit arrival time (set to 15 minutes before the scheduled appointment) affects when patients arrive for their appointments, compared to a control condition where only the appointment time is displayed and patients are encouraged to arrive 15 min before the appointment (without an explicit arrival time).

Conditions

  • Primary Care

Interventions

BEHAVIORAL

Behaviorally informed appointment communications

In the MyChart patient portal homepage, the appointment widget will show "Arrive by \[Arrival Time\]," replacing the standard "Starts at \[Appointment Time\]" display. The appointment details page will show appointment time, along with a reminder to "Arrive by \[Arrival Time\]." The Hello World text notifications will tell patients: "Your visit is scheduled for \[Date\]. Arrive by \[Arrival Time\]."

BEHAVIORAL

Control appointment communications

In the MyChart patient portal homepage, the appointment widget will show "Starts at \[Appointment Time\]." The appointment details page will display appointment time, along with the instructions to arrive 15 minutes before the appointment. The Hello World text notifications will tell patients : "Your visit is scheduled for \[Date\] at \[Appointment Time\]. Please arrive 15 minutes before your appointment time."

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-05
Primary Completion
2026-07-31
Completion
2026-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07314697 on ClinicalTrials.gov